Crestline Management, L.P. Portfolio Stock Holdings

Crestline Management, L.P. disclosed 3 stock positions valued at approximately $46.3 million in its latest SEC 13F filing. The largest holdings include DENALI THERAPEUTICS INC, SANA BIOTECHNOLOGY INC, and 8X8 INC NEW. The filing reflects positions held as of March 31, 2026 and was filed on May 15, 2026.

Report Period
March 31, 2026
No. of Stocks
3
Portfolio Value
$46.3M
Holdings by Sector
Crestline Management, L.P. Portfolio Holdings in Q1 2026

3 holdings in the latest reporting period.

Page 1 of 1
CompanySymbolSectorPortfolio %SharesChange (Shares)Change %Value
DENALI THERAPEUTICS INCDNLIHealthcare91.74%2,210,732-600,000-21.35%$42,446,054
SANA BIOTECHNOLOGY INCSANAHealthcare4.70%755,736-465,201-38.10%$2,176,520
8X8 INC NEWEGHTTechnology3.56%990,850+270+0.03%$1,644,811